Quick Asked: Forest Laboratories Inc Contact Us?

Are you searching for Forest Laboratories Inc Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 24 Apr, 2024 361 Views

Is forest laboratories still in business? Footnotes / references. Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis (now Allergan).

What are the main therapeutic areas of forest laboratories? The main therapeutic areas that the company concentrates on include depression, Alzheimer's disease/neuropathic pain, hypertension, asthma, and gastrointestinal disease. Since its introduction in 1998, the antidepressant drug Celexa has been Forest's blockbuster, accounting for nearly 70 percent of company revenues by fiscal 2002.

Why choose forest pharmaceuticals? We aim to help each and every American in that situation. Forest Pharmaceuticals, Inc is the United States and Puerto Rico subsidiary of Forest Laboratories, Inc. (Founded in 1956). Forest Laboratories, Inc. has focused their research and development into the fields of central nervous system, cardiovascular, and respiratory system.

When did forest laboratories buy uad laboratories? In 1989, for instance, Forest acquired UAD Laboratories for $33 million in stock. This deal increased the sales force to 300 and added to the company portfolio a narcotic analgesic product, Lorcet, which within a few years had annual sales of $60 million.

Listing Results Forest Laboratories Inc Contact Us? Question Answers

FOREST LABORATORIES, INC. : Stock Price US3458381064

FOREST LABORATORIES : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results. BU. 2014. FOREST LABORATORIES : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD) BU. Summary.

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.